Health care startups that raised Series C in Massachusetts, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Delix Therapeutics | Boston | Series C | $100.0M | 2026-11-09 |
| Ratio Therapeutics | Boston | Series C | $70.0M | 2026-07-31 |
| Triveni Bio | Watertown | Series C | $65.0M | 2026-06-17 |
| InStride Health | Boston | Series C | $30.0M | 2026-06-15 |
| CereVasc | Charlestown | Series C | $85.0M | 2026-06-04 |
| Cerevance | Boston | Series C | $20.0M | 2026-05-12 |
| Iterative Health | Cambridge | Series C | $77.0M | 2026-04-30 |
| AcuityMD | Boston | Series C | $80.0M | 2026-04-21 |
8 rows of the CSV in 5 of its 18 columns.
- The 97 health care startups in Massachusetts, United States whose last round is Series C have raised $11.3B in total.
- 14 of them closed their most recent round in the last 12 months, $825.0M combined.
- The largest of those rounds is Cognito Therapeutics' $105.0M Series C, dated March 2026.
- The most recent is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- RA Capital Management is an investor in 4 of them, more than any other fund.
- Biotech is the most common other sector, with 65 companies (67%).
- 7% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (43% of companies with a recorded size).
- 2 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
20 of 97| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Boston | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| Triveni Bio | Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. | Biotech | Watertown | Series C | $65.0M | 2026-06-17 | $272.0M | Polaris Partners, OrbiMed, Alexandria Venture Investments +2 | 11 to 50 | 2019 |
| InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Boston | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
| CereVasc | CereVasc develops a minimally invasive treatment for communicating hydrocephalus. | Biotech | Charlestown | Series C | $85.0M | 2026-06-04 | $199.0M | Perceptive Advisors, Bain Capital Life Sciences, ATON Partners | 11 to 50 | 2014 |
| Cerevance | Cerevance develops novel therapeutics for neurological diseases. | Biotech | Boston | Series C | $20.0M | 2026-05-12 | $209.5M | Google Ventures, Casdin Capital, Foresite Capital +1 | 51 to 100 | 2016 |
| Iterative Health | Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. | Artificial intelligence | Cambridge | Series C | $77.0M | 2026-04-30 | $268.6M | Plug and Play, Alumni Ventures, Insight Partners +1 | 251 to 500 | 2017 |
| AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Boston | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Cambridge | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
| Cognito Therapeutics | Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. | Biotech | Cambridge | Series C | $105.0M | 2026-03-05 | $321.8M | Morningside, FoundersX Ventures, IAG Capital Partners +1 | 11 to 50 | 2016 |
| NanoHive Medical | NanoHive Medical makes 3D-printed spinal interbody implants and instruments. | Health care | Woburn | Series C | $7.0M | 2024-08-05 | $7.0M | Sky Ventures Group | 11 to 50 | 2014 |
| Sionna Therapeutics | Sionna Therapeutics develops small molecule therapies for treating cystic fibrosis. | Biotech | Natick | Series C | $182.0M | 2024-03-06 | $292.0M | RA Capital Management, OrbiMed, T. Rowe Price +2 | 11 to 50 | 2018 |
| Overjet | Overjet is a software company that offers an AI platform for dentistry and educates patients. | Artificial intelligence | Boston | Series C | $53.2M | 2024-03-05 | Insight Partners, General Catalyst, Liquid 2 Ventures +2 | 101 to 250 | 2018 | |
| Accent Therapeutics | Accent Therapeutics is a biopharmaceutical company. | Biotech | Lexington | Series C | $75.0M | 2024-01-23 | $178.0M | Google Ventures, Mirae Asset Venture Investment, Bristol-Myers Squibb +2 | 11 to 50 | 2017 |
| Access Vascular | Access Vascular develops novel hydrophilic-based medical devices that improve venous access. | Health care | Bedford | Series C | $22.0M | 2023-10-31 | $57.1M | MedTech Innovator, TVM Capital Life Science, AngelMD | 11 to 50 | 2015 |
| IntelyCare Unicorn | IntelyCare provides a workforce management platform for healthcare staffing, scheduling, and training. | Health care | Quincy | Series C | $115.0M | 2022-04-06 | $170.8M | LRVHealth, Eastward Capital Partners, Longitude Capital +2 | 251 to 500 | 2014 |
| ConcertAI Unicorn | ConcertAI sells AI-powered SaaS data tools for medical research in oncology. | Artificial intelligence | Cambridge | Series C | $150.0M | 2022-03-29 | $300.0M | Maverick Ventures, Sixth Street, Declaration Partners +2 | 1,001 to 5,000 | 2018 |
| Hospital IQ | Hospital IQ provides a web-based analytics platform that helps hospitals improve operational efficiency. | Health care | Newton | Series C | $25.0M | 2021-06-28 | $48.2M | Longworth Venture Partners, Open Field Capital, Health Velocity Capital | 11 to 50 | 2013 |
| SupplyScape | SupplyScape provides electronic pedigree solutions for the pharmaceutical industry. | Health care | Woburn | Series C | $10.0M | 2007-09-06 | $29.0M | Flybridge, Chiratae Ventures, North Bridge Venture Partners & Growth Equity +1 | 251 to 500 | 2003 |
| deNovis | deNovis provides transaction processing and information management software for health insurers. | Commerce | Lexington | Series C | $22.0M | 2004-01-12 | 3i Group, Bain Capital, JP Morgan Chase +2 | 1999 |
Table 1. Health care startups that raised Series C in Massachusetts, United States: the 20 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 97.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cognito Therapeutics | Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. | Biotech | Cambridge | Series C | $105.0M | 2026-03-05 | $321.8M | Morningside, FoundersX Ventures, IAG Capital Partners +1 | 11 to 50 | 2016 |
| 2 | Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| 3 | CereVasc | CereVasc develops a minimally invasive treatment for communicating hydrocephalus. | Biotech | Charlestown | Series C | $85.0M | 2026-06-04 | $199.0M | Perceptive Advisors, Bain Capital Life Sciences, ATON Partners | 11 to 50 | 2014 |
| 4 | AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Boston | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| 5 | Iterative Health | Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. | Artificial intelligence | Cambridge | Series C | $77.0M | 2026-04-30 | $268.6M | Plug and Play, Alumni Ventures, Insight Partners +1 | 251 to 500 | 2017 |
| 6 | Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Boston | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| 7 | Triveni Bio | Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. | Biotech | Watertown | Series C | $65.0M | 2026-06-17 | $272.0M | Polaris Partners, OrbiMed, Alexandria Venture Investments +2 | 11 to 50 | 2019 |
| 8 | Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Cambridge | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
| 9 | InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Boston | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
| 10 | Cerevance | Cerevance develops novel therapeutics for neurological diseases. | Biotech | Boston | Series C | $20.0M | 2026-05-12 | $209.5M | Google Ventures, Casdin Capital, Foresite Capital +1 | 51 to 100 | 2016 |
Table 2. Health care startups that raised Series C in Massachusetts, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator | Boston, United States | 4 | 4% | 2 | Delix Therapeutics, Terrestrial Bio |
| 2 | Invus | Private equity firm | New York, United States | 3 | 3% | 1 | Triveni Bio |
| 3 | Polaris Partners | Private equity firm | Boston, United States | 3 | 3% | 1 | Triveni Bio |
| 4 | OrbiMed | Private equity firm | New York, United States | 3 | 3% | 1 | Triveni Bio |
| 5 | Google Ventures | Corporate venture arm | San Francisco, United States | 3 | 3% | 1 | Cerevance |
| 6 | F-Prime | Venture capital firm | Cambridge, United States | 3 | 3% | ||
| 7 | Bristol-Myers Squibb | Venture capital firm | New York, United States | 2 | 2% | 1 | Ratio Therapeutics |
| 8 | .406 Ventures | Venture capital firm | Boston, United States | 2 | 2% | 1 | InStride Health |
| 9 | General Catalyst | Venture capital firm | San Francisco, United States | 2 | 2% | 1 | InStride Health |
| 10 | Insight Partners | Private equity firm | New York, United States | 2 | 2% | 1 | Iterative Health |
| 11 | Longitude Capital | Venture capital firm | Menlo Park, United States | 2 | 2% | ||
| 12 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 2 | 2% | ||
| 13 | Janus Henderson Investors | Private equity firm | London, United Kingdom | 2 | 2% | ||
| 14 | The Blue Venture Fund | Private equity firm | Chicago, United States | 2 | 2% | ||
| 15 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 2 | 2% |
Table 3. Health care startups that raised Series C in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 65 | 67% | $9.3B |
| Software | 26 | 27% | $2.8B |
| Artificial intelligence | 10 | 10% | $1.7B |
| Hardware | 3 | 3% | $369.5M |
| Commerce | 2 | 2% | $56.9M |
| Education | 1 | 1% | $12.0M |
| Fintech | 1 | 1% |
Table 4. Health care startups that raised Series C in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 97 | 100% | $37.0M |
Table 5. Health care startups that raised Series C in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups that raised Series C in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 14% | $115.0M |
| September 2026 | 1 | 7% | $6.0M |
| July 2026 | 2 | 14% | $107.0M |
| June 2026 | 4 | 29% | $265.0M |
| May 2026 | 1 | 7% | $20.0M |
| April 2026 | 2 | 14% | $157.0M |
| March 2026 | 2 | 14% | $155.0M |
Table 7. Health care startups that raised Series C in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 14 | 14% | $825.0M |
| 2025 | 11 | 11% | $642.7M |
| 2024 | 7 | 7% | $674.5M |
| 2023 | 4 | 4% | $179.5M |
| 2022 | 9 | 9% | $771.9M |
| 2021 | 8 | 8% | $352.0M |
Table 8. Health care startups that raised Series C in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 7 | 7% |
| 2015 to 2019 | 38 | 39% |
| 2010 to 2014 | 22 | 23% |
| Before 2010 | 30 | 31% |
Table 9. Health care startups that raised Series C in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 5 | 5% |
| 11 to 50 | 41 | 43% |
| 51 to 100 | 23 | 24% |
| 101 to 250 | 16 | 17% |
| 251 to 500 | 8 | 8% |
| 501 to 1,000 | 2 | 2% |
| 1,001 to 5,000 | 1 | 1% |
Table 10. Health care startups that raised Series C in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series C and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 97 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 20 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 97 rows: 5 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Massachusetts, United States whose last round is Series C are on the list?
- 97, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 97 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.